National Drug Strategy
National Drug Strategy

Comorbidity of mental disorders and substance use: a brief guide for the primary care clinician

9.3 Major clinical issues with eating disorders and cannabis/ hallucinogen use

prev pageTOC |next page

Table of contents

9.3.1 Effects of cannabis and other hallucinogens on eating disorders

9.3.2 Interactions between cannabis and other hallucinogens and therapeutic agents for eating disorders

9.3.3 Management approaches to comorbid eating disorders and cannabis or other hallucinogen use

prev pageTOC |next page